NEW YORK--(BUSINESS WIRE)--Nov 2, 2023--Nuvation Bio Inc. (NYSE: NUVB), a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates, today reported its financial results for the third quarter ended September 30, ...
TOULOUSE, France & LAKELAND, Mich.--(BUSINESS WIRE)--Nov 2, 2023--<em>ABIONYX Pharma</em>, ( <em>FR0012616852 - ABNX - PEA PME eligible)</em>, a new generation biotech company dedicated to the discovery and development of ...
FOSTER CITY, Calif.--(BUSINESS WIRE)--Nov 2, 2023--Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced the publication of abstracts from the IMerge Phase 3 clinical trial evaluating its first-in-class investigational telomerase inhibitor imetelstat ...
CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--Nov 2, 2023--Bicycle Therapeutics plc (NASDAQ: BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide ( <em>Bicycle 庐</em> ) ...
LONDON--(BUSINESS WIRE)--Nov 2, 2023--Prokarium, a biopharmaceutical company at the forefront of applying synthetic biology to create novel cancer treatments, today announces that the U.S. Food and Drug Administration (FDA) has granted the company's Investigational New Drug (IND) application ...
SAN DIEGO--(BUSINESS WIRE)--Nov 1, 2023--Genome Insight, a precision healthcare solutions company promoting whole-genome technology for accurate diagnosis and personalized treatment for cancer and rare disease, today announced that it has closed a $23 million in a Series B-2 investment in its ...